Ketamine HCl Injection Solution Recalled for Labeling and Expiration Date Errors
Prisma Health Outsourcing Facility is recalling Ketamine HCl Injection Solution (10 mg / 2 mL) distributed in South Carolina due to incorrect expiration dates and incorrect Beyond Use Dates (BUD) on the labeling.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving labeling errors (incorrect expiration date and BUD). The source text does not report any illnesses, injuries, or deaths. Per the rubric, FDA Class III recalls are typically scored 1 or 2, and labeling errors without reported adverse events fall under the "Moderate" category as minor labeling errors.
Plain-English summary
Prisma Health Outsourcing Facility is recalling Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, with NDC 73463-0100-01, manufactured by Prisma Health Outsourcing Facility in Simpsonville, South Carolina. The recall affects 109 syringes from lots K10521042 and K20521043 with an expiration date of 08/31/2021. The product was distributed in South Carolina.
The recall was initiated due to incorrect expiration dates and incorrect Beyond Use Dates (BUD) printed on the product labeling. Inaccurate expiration and BUD dates may prevent healthcare providers from properly assessing product stability and safety.
Healthcare providers and patients who have received this product should contact their pharmacy or healthcare facility for guidance. Patients should not use this product if they possess it and should return it to their healthcare provider or pharmacy.
The recalled product
- Product
- Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, Compounded by Prisma Health Outsourcing Facility 1071 Holland Rd. Suite 2 Simpsonville, SC 29681. NDC: 73463-0100-01
- Manufacturer
- Prisma Health Outsourcing Facility
- Category
- Drug — Compounded Injection
- Affected units
- 109
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots: K10521042 and K20521043 Exp. 08/31/2021.
Distribution
Distributed in 1 state:
Related recalls
Same hazard · mis labeling
See all →- High
- HighBetterballen Foods Frozen Meat and Poultry Products Alerted for Undeclared Allergens
USDA FSIS · 2026-11-06
- LowMeitheal Pharmaceuticals Recalls Vecuronium Bromide Injection for Labeling Defect
FDA (Drugs) · 2026-11-04
- LowValuHealth Acetaminophen Recalled for Incorrect Bottle Label
FDA (Drugs) · 2026-11-04
- SevereRiad's Oliva to Go Hummus Recalled for Undeclared Sesame
FDA (Food) · 2026-11-04
Similar recalls
- SeverePharmedium Recalls Ketamine HCl Injection Due to Stability Data Concerns
FDA (Drugs) · 2016-10-19
- HighKetamine HCl Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-07-27
- SeverePharmedium Recalls Ketamine HCl Injection Due to Potential Loss of Potency
FDA (Drugs) · 2016-10-19
- ModerateKetamine syringes recalled over incorrect or missing lot and expiry
FDA (Drugs) · 2025-10-22
- SevereSCA Pharmaceuticals Recalls Ketamine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13
- HighKetamine HCl Injection Syringes Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27